Clinical Trial Update: An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update shows that the Phase 2 study of beloranib in obese subjects with Type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Beloranib (Beloranib)

Snippet

Sponsor: Zafgen, Inc. | Conditions: Obesity, Type 2 Diabetes | Phase 2 | Status: TERMINATED